"10.1371_journal.pone.0103650","plos one","2014-08-19T00:00:00Z","Jeanine F Amacher; Ruizhi Zhao; Mark R Spaller; Dean R Madden","Department of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America; Department of Chemistry, Dartmouth College, Hanover, New Hampshire, United States of America; Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States of America; Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America","Conceived and designed the experiments: JFA RZ MRS DRM. Performed the experiments: JFA RZ. Analyzed the data: JFA RZ MRS DRM. Contributed reagents/materials/analysis tools: JFA RZ MRS DRM. Contributed to the writing of the manuscript: JFA MRS DRM.","Dr. Madden is a co-inventor on patent filings covering the therapeutic use of CAL inhibitor peptides. Patent number is 8,415,292, issued 4/9/13. This does not alter the authors adherence to all PLOS policies on sharing data and materials.","2014","08","Jeanine F Amacher","JFA",4,TRUE,4,2,4,NA,TRUE,TRUE,FALSE,0,NA,FALSE
